Ligand Pharmaceuticals (LGND) is scheduled to announce Q2 earnings results on Thursday, August 6th, before market open. – The consensus EPS Estimate is $1.95 (+21.9% Y/Y) and the consensus Revenue Estimate is $60.76M (+27.6% Y/Y). – Over the last 2 years, LGND
Ligand Pharmaceuticals Q2 2026 Earnings Preview
Ligand Pharmaceuticals (LGND) is scheduled to announce Q2 earnings results on Thursday, August 6th, before market open. - The consensus EPS Estimate is $1.95 (+21.9% Y/Y) and the consensus Revenue Estimate is $60.76M (+27.6% Y/Y). - Over the last 2 years, LGND